Skip to content

Testing a tailored Home Exercise program to Gain insight into performance fatigability and Reduce pain and fatigue In Patients with FSHD: THE GRIP on FSHD study

Testing a tailored Home Exercise program to Gain insight into performance fatigability and Reduce pain and fatigue In Patients with FSHD: THE GRIP on FSHD study - THE GRIP on FSHD study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57247
Enrollment
30
Registered
2024-07-29
Start date
2025-04-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facioscapulohumeral Dystrophy

Interventions

An individualized exercise program consisting of aerobic exercises, strength exercises and balance exercises. The exercises will be prescribed via the Physitrack app.

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age > 18 years - Verified diagnosis of FSHD type 1 or 2, based on the clinical criteria established  by Padberg et al. (1991). - Category A or B of the four clinical categories according to the  Comprehensive Clinical Evaluation Form, these patients have the most peculiar  signs of the disease  - A CIS-fatigue score of >= 35 - Owning and being able to use a smartphone - Preserved ability to ambulate at the time of the selection  - No cardiological or pulmonary involvement, that could interfere with physical  training.  - Absence of central or peripheral nervous system involvement as from  neurological history and physical assessment  - Absence of limb contractures and tendon retractions

Exclusion criteria

Exclusion criteria: - Use of beta-blocker medication - Presence of additional diseases likely to interfere with the measurements - Psychological-psychiatric disorders - A musculoskeletal injury that impairs exercising - Scoliosis that impairs training - Recent adjustment of any medications or medications that may impact fatigue or taking stimulants for fatigue (e.g., Modafinil, amantadine) - Current participation in another clinical investigation of a medical device or a drug; or has participated in such a study within 30 days prior to this study - Pregnant women - Patient incapable of understanding the purpose and conditions of the study, incapable of giving consent - Patient deprived of liberty or patient under guardianship

Design outcomes

Primary

MeasureTime frame
The chronic fatigue score assessed using the Checklist Individual Strength (CIS-fatigue) fatigue subscale and the daily observed pain score during 2 weeks are the primary endpoints.

Secondary

MeasureTime frame
Muscle function (MRC score), the Quadriceps Isometric Intermittent Fatigue test, B-FIT exercise test, Forced Vital Capacity, Mini-BESTest, physcial activity with an activity tracker, and questionnaires regarding pain, sleep, participation and physical function.

Countries

Netherlands

Contacts

Public ContactN. Voet

Radboud Universitair Medisch Centrum

Nicole.Voet@radboudumc.nl(024) 3655286

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026